Akura Medical
Los Gatos
About Akura Medical
Akura Medical offers products and services centered on mechanical thrombectomy and imaging software for venous thromboembolism treatment. Its Katana Thrombectomy System uses a steerable catheter with integrated jet-based technology to access clot material, break it down, and support clot removal during a procedure. The system provides procedural feedback intended to help clinicians assess clot engagement and clearance while operating the device. Akura Medical also develops NavIQ, a software tool that transforms CT angiograms into 3D vascular models that display clot location and morphology to guide procedural planning. Together, these products form a workflow that supports physicians from pre-procedure assessment through clot extraction in cases involving pulmonary embolism and related VTE conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $113.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2025)
- Website: akuramed.com
- Phone: +1 408 560 2500
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/akura-medical-81982 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.